FACTANKER
Altamira Therapeutics Ltd.: xbrl:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset
Value
{"unit": "CHF", "value": -215156}
Period
2019-01-01 – 2019-12-31
Status
current
Entity
Altamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-20-009292
Retrieved: 2026-08-19T16:24:22.861909+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER,
https://factanker.com/fact/cf3e42b4-5192-4147-9feb-115529d8016a
History
no predecessors — first report